Fed Circ written description ruling overturns $1.2 billion award

26-08-2021

Alex Baldwin

Fed Circ written description ruling overturns $1.2 billion award

Piotr Swat / Shutterstock.com

Kite Pharma has successfully persuaded the US Court of Appeals for the Federal Circuit to reverse a $1.2 billion win for the Bristol-Meyers Squibb owned Juno Therapeutics over a cancer treatment patent.


Kite Pharma, Bristol-Meyer’s, Juno Therapeutics, US District Court for the Central District of California, US Court of Appeals for the Federal Circuit

LSIPR